KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Charles River Laboratories International (CRL) Accumulated Depreciation & Amortization (2016 - 2025)

Charles River Laboratories International has reported Accumulated Depreciation & Amortization over the past 17 years, most recently at $403.3 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $403.3 million for Q4 2025, up 11.49% from a year ago — trailing twelve months through Dec 2025 was $403.3 million (up 11.49% YoY), and the annual figure for FY2025 was $403.3 million, up 11.49%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $403.3 million at Charles River Laboratories International, up from $85.2 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for CRL hit a ceiling of $403.3 million in Q4 2025 and a floor of $85.2 million in Q3 2025.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $120.4 million (2025), compared with a mean of $203.0 million.
  • Peak annual rise in Accumulated Depreciation & Amortization hit 41.01% in 2025, while the deepest fall reached 3.44% in 2025.
  • Charles River Laboratories International's Accumulated Depreciation & Amortization stood at $265.5 million in 2021, then grew by 14.43% to $303.9 million in 2022, then increased by 3.37% to $314.1 million in 2023, then increased by 15.16% to $361.7 million in 2024, then rose by 11.49% to $403.3 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $403.3 million (Q4 2025), $85.2 million (Q3 2025), and $119.5 million (Q2 2025) per Business Quant data.